16-Dehydro-pregnenolone/Atorvastatin
双烯醇酮乙酸酯/阿托伐他汀
Report date: 2022/01/14 13:23:58
Base Information
Drug Name16-Dehydro-pregnenolone/Atorvastatin
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Atorvastatin Calcium Hydrate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCadila Pharmaceuticals LtdCdri
China Registration ClassN/A
Develop Information
Active CompaniesCdriZydus Lifesciences Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A